Document is current
Any future updates will be listed below
-
Authors
Turk, Fatih Can https://orcid.org/0009-0007-5748-1481
Onal, Burak https://orcid.org/0000-0002-7846-875X
Celik, Zulal https://orcid.org/0009-0004-3167-8508
Akkan, Ahmet Gökhan https://orcid.org/0000-0002-6799-1721
Özyazgan, Sibel https://orcid.org/0000-0002-2511-3541
-
Funding
Funding for this research was provided by:
Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi
- License Information
-
More Information
Article History
Received: 23 January 2026
Accepted: 21 April 2026
First Online: 30 April 2026
Declarations
:
: This study was conducted exclusively using a commercially available, established human endothelial cell line (HUVECs; ATCC, CRL-1730™). No human participants, human-derived biological samples, or animal subjects were involved. According to national regulations and institutional guidelines in Türkiye, ethical approval from a local ethics committee or Institutional Review Board (IRB) is not required for in vitro studies performed solely with purchased cell lines. Therefore, ethics committee approval was not applicable for this study.
: Not applicable.
: The authors declare no competing interests.
